DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives

Mariaelena Repici, Flaviano Giorgini

Research output: Contribution to journalReview articlepeer-review


Mutations in the protein DJ-1 cause autosomal recessive forms of Parkinson’s disease (PD) and oxidized DJ-1 is found in the brains of idiopathic PD individuals. While several functions have been ascribed to DJ-1 (most notably protection from oxidative stress), its contribution to PD pathogenesis is not yet clear. Here we provide an overview of the clinical research to date on DJ-1 and the current state of knowledge regarding DJ-1 characterization in the human brain. The relevance of DJ-1 as a PD biomarker is also discussed, as are studies exploring DJ-1 as a possible therapeutic target for PD and neurodegeneration.
Original languageEnglish
Article number1377
JournalJournal of Clinical Medicine
Issue number9
Publication statusPublished - 3 Sept 2019

Bibliographical note

© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (

Funding: Wellcome Trust WT-ISSF.


Dive into the research topics of 'DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives'. Together they form a unique fingerprint.

Cite this